Treatment of allergic aspergillosis with triamcinolone acetonide aerosol.
The successful management of a patient with allergic asperillosis with triamcinolone acetonide for one year is reported. This patient had been maintained previously on systemic attempt to withdraw systemic corticosteroids continuously for eight years. An initial attempt to withdraw systemic steroids after initiation of aerosol therapy was unsuccessful; however, following bronchoscopic removal of mucus plugs, the transfer to maintenance therapy with triamcinolone aerosol alone was uneventful.
D000328:Adult; D000336:Aerosols; D001228:Aspergillosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008172:Lung Diseases, Fungal / Q000188:drug therapy*; D012130:Respiratory Hypersensitivity / Q000188:drug therapy*; D014221:Triamcinolone / Q000008:administration & dosage / Q000627:therapeutic use*
D000336:Aerosols; D014221:Triamcinolone